
price close busi may
biomed devic servic
reinforc growth thesi
reiter buy pt
bottom line reiter buy rate follow unequivoc strong
came well ahead our/street expect deliv anoth quarter
strong sensor volum ou sale new patient add compani continu
benefit grow cgm awar view technolog superior
product critic point bullish thesi recent reinforc recent
endo survey link look forward manag highlight continu invest
dtc ou expans pipelin support growth beyond
sum continu expect battleground stock investor
choos side cgm market come confid
abil deliv upsid current estimates/guid especi heel new
product launch buy
result post revenu y/i cg/consensu
top-lin strength support broad strength across
segment includ ou growth y/i us growth y/i
specif us sale benefit continu momentum medicar channel
strong sensor volum commerci patient addit addit manag
note dtc advertis includ libr help drive broader patient awar
cgm someth expect continu
impact obsolet inventori charg prior gen receiv unfavor mix
ous/medicar upgrad program despit shortfal manag
reiter expect gm adjust ep came
well cg/street estim
earli launch track well call manag note phenomen earli
feedback limit launch reiter expect broader
launch ahead ada meet june specif manag highlight
elimin fingerstick calibr maintain industry-lead accuraci
simplic new sensor applic remind notabl featur
includ extend sensor wear time day vs previous updat hardwar
compon includ new receiv thinner/ lighter transmitt reduc
importantli least competit come factori calibr addit
detail survey note
medicar continu support growth manag longer break
medicar contribut sale highlight medicar contributor
strong us growth estim medicar revenu grew q/q remind
upsid encourag continu execut patient demand expect
materi driver y/i us patient growth
ou growth y/i ou impress reimburs tailwind
strength key direct sale market manag highlight signific ou
busi make total revenu reiter plan continu
invest ou commerci infrastructur
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
chang estim
given strong increas revenu guidanc rang
y/i manag expect
growth support sensor volum ou expans ww instal
base gross margin guidanc reiter rang opex
still expect increas y/i made follow chang
adjust revenu estim
lp estim
adjust revenu estim
lp estim
adjust revenu estim
ep estim
adjust revenu estim
lp estim
adjust revenu estim
ep estim
adjust revenu estim
ep estim
buy unchang target price may
biomed devic servic
resultsactualcg estbeat/miss beat/miss consensusbeat/miss total revenu total gross oper result categoryactualcg estbeat/missbeat/miss prior yeary/i growthnet sale
figur summari estim revis
high-growth med-tech comp group current trade mean ev/sal multipl
estim revenu sum increas price target
base valuat ev/sal multipl appli
revenu estim price target assum cash
debt share outstand
figur matrix discount rate impli share price target
buy unchang target price may
biomed devic servic
oldnew oldnew oldnew revenu comp ev/sal multipl price metric use ev/sal valuat growth medic devic ev/sal multipl sale share outstand figur dexcom incom statement
canaccord genuiti estim compani report detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
buy unchang target price may
biomed devic servic
canaccord genuiti estim compani report compani report
buy unchang target price may
biomed devic servic
